Vasculitis (systemic vasculitides) Flashcards

1
Q

What are systemic vasculitides

A

Autoimmune mediated inflammation of blood vessels –> BV necrosis

There are pauci-immune variants

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Pathognomonic features of systemic vasculitides

A
  • Fibrinoid necrosis of BV wall
  • Karyorrhexis of BV wall
  • RBC extravasation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

How are systemic vasculitides classified

A

Large, medium, small vessel vasculitides

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q
  1. What are ANCAs?
  2. What are the 2 types of ANCAs?
  3. How do they relate to vasculitides?
A
  1. Anti-neutrophil cytoplasmic antibodies
  2. c-ANCA = cytoplasmic
    p-ANCA = perinuclear
  3. small vessel vasculitides are classified into ANCA + non-ANCA mediated
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Give an important example of a large vessel vasculitis

A

Giant cell arteritis (GCA)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

GCA pathophysiology

A

DCs attract CD4 cells to arteries via vasa vasorum where they become active + undergo clonal expansion. They activate tissue macrophages in the media which:

(1) release cytokines –> systemic inflammation
(2) MMP + ROS release –> oxidative stress –> destruction of internal elastic lamina –> media + intima separate
(3) form multinucleate giant cells (IFNg, IL1, IL6)

Damaged blood vessels respond by releasing VEGF/PDGF –> new blood vessel formation + intimal thickening –> luminal narrowing –> ischemia –> symptoms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

GCA pathophysiology

A

DCs attract CD4 cells to arteries via vasa vasorum where they become active + undergo clonal expansion. They activate tissue macrophages in the media which:

(1) release cytokines –> systemic inflammation
(2) MMP + ROS release –> oxidative stress –> destruction of internal elastic lamina –> media + intima separate
(3) form multinucleate giant cells (IFNg, IL1, IL6)

Damaged blood vessels respond by releasing VEGF/PDGF –> new blood vessel formation + intimal thickening –> luminal narrowing –> ischemia –> symptoms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

GCA clinical Px

A

F > M (2:1)
typically >50yo

(1) Headache (new onset + scalp tenderness)
(2) Sudden painless loss of vision/diplopia
(3) Jaw/tongue claudication
(4) temporal artery tenderness / reduced pulsations
(5) polymyalgia rheumatica (30%)
(6) aortic arch syndrome (involvement of subclavian + brachial arteries –> pulseless disease)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

GCA Cx

A

(1) increased risk of thoracic aortic aneurism –> rupture

(2) permanent blindness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

GCA Ix

A

ESR

temporal artery biopsy (+/- US)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

GCA Dx criteria

A

3+ of the following:

(1) Age >50
(2) New headache
(3) temporal artery tenderness/reduced pulsations
(4) ESR high
(5) Arterial abnormality on biopsy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

GCA Rx

A

(1) high-dose prednisolone (bisphosphonates, vit D, calcium, PPI)
(2) yearly CXR +/- abdominal US to screen for aortic aneurism
(3) consider aspirin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Why is GCA a medical emergency? Name another serious cx

A

Untreated –> permanent blindness in 20-25%

Thoracic aortic aneurism rupture

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Why is GCA a medical emergency? Name another serious cx

A

Untreated –> permanent blindness in 20-25%

Thoracic aortic aneurism rupture

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Important example of medium vessel vasculitis

A

Polyarteritis nodosa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Pathophysiology of polyarteritis nodosa

A

Necrotising vasculitis –> thrombosis/dilation/aneurism of affected vessel.

Healed lesions may result in fibrosis + endothelial proliferation –> luminal narrowing/occlusion (ischemia)

May be associated w. HBV in some cases

17
Q

Dx criteria for polyarteritis nodosa (10)

A

3+ of the following:

(1) weight loss >4kg w/o other explanation
(2) DBP > 90mmHg
(3) Neuropathy (poly/mono)
(4) HBV +
(5) Livedo reticularis = mottled skin
(6) MSK = diffuse weakness/tenderness
(7) Testicular = pain/tenderness (w/o other explanation)
(8) Cr/BUN elevated
(9) Angiography abnormal
(10) arterial biopsy –> granulocytes/mononuclear lymphocytes in arterial wall

18
Q

Dx criteria for polyarteritis nodosa (10)

A

3+ of the following:

(1) weight loss >4kg w/o other explanation
(2) DBP > 90mmHg
(3) Neuropathy (poly/mono)
(4) HBV +
(5) Livedo reticularis = mottled skin
(6) MSK = diffuse weakness/tenderness
(7) Testicular = pain/tenderness (w/o other explanation)
(8) Cr/BUN elevated
(9) Angiography abnormal
(10) arterial biopsy –> granulocytes/mononuclear lymphocytes in arterial wall

19
Q

Polyarteritis nodosa Rx

A

Meticulous BP control
Prednisolone + cyclophosphamide
HBV Rx (if infected)

20
Q

4 features of small vessel vasculitis

A

(1) palpable purpura
(2) vesicles
(3) chronic urticaria
(4) superficial ulcers